“It’s what every physician should be using for a very easy and accessible way to look at a biomarker of longevity.” That biomarker is red blood cell distribution width (RDW), an emerging measure linked to biological aging and resilience. As new science begins to quantify longevity, healthcare leaders are defining what it means in practice. Join Dr. Stephanie Venn-Watson, CEO & Co-founder of fatty15, and other leaders at Fullscript Forward (Oct. 17, 12–3 p.m. EST) as they explore how to translate emerging data into frameworks for root-cause longevity care. Free for all providers — reserve your seat today: https://bit.ly/3VIid7C